NKTR - Nektar Therapeutics Inc. Price Chart

Official company branding of nektar.com (NKTR)

The current market quotes for Nektar Therapeutics (NKTR) visualized below demonstrate the price action of an asset valued at 36.51. This recognized biopharmaceutical expert leverages years of experience in developing modified molecules to combat oncology. The business targets the global biotech market, offering the B2B sector solutions to reduce therapy toxicity. Nektar Therapeutics (NKTR) is currently implementing a rigorous restructuring plan, focusing on drugs for autoimmune pathologies.

Nektar Therapeutics - NKTR Price (period 07/04/2022 - 11/17/2026)

Nektar - analytical breakdowns and key metrics (NKTR)

- stock value and consensus price forecast:
- market capitalization statistics:
Fundamental valuation:nektar.com
Signature product of Nektar Therapeutics Inc

Price represents the consolidated result of market transactions, reflecting the current market value of the asset. This indicator aggregates investor expectations regarding future cash flows and risks. By analyzing current security quotes on the GURU.Markets platform, one can identify the dominant market trend. Price action depends directly on the success of clinical trials and the volume of licensing payments. For Nektar Therapeutics (NKTR), this reflects the commercial potential of their biopharmaceutical developments.

Analysis of competing companies

Stock Price ARGX|Price Chart BNTX (BioNTech Inc.)|Stock Price ABVX (Abivax S.A.)|ADMA: Share Price|Protagonist Corp - Stock Price|IMVT: Price Chart|KNSA: Stock Price|GRFS - Market Chart|Price Chart Adaptive Biotechnologies Corporation|Celldex - Quote Chart|Stock Price AUPH|BCRX (BioCryst) - Price Performance Chart|Stock Price VERA (veratx.com)|Stock Price Dianthus Therapeutics Inc DNTH|PHVS - Price Chart|Price Performance Chart ABCL (AbCellera Biologics Inc.)|tourmalinebio.com (TRML) - Price Chart|Stock Quotes Precigen, Inc.|PHAR (pharming.com) - Stock Price|UPB: Price Performance Chart|Stock Quotes ZBIO (Zenas Biopharma, Inc.)|IMNM (Immunome Corp) - Price Performance Chart|Stock Price GOSS (gossamerbio.com)|Market Chart kalvista.com (KALV)|SEPN - Price Chart|Pieris Pharma (PVLA) - Stock Quotes|Savara Pharma (SVRA) - Price Chart|Stock Quotes Rigel Pharmaceuticals|Stock Quotes ANAB|Stock Price astriatx.com|Price Chart enGene Bio (ENGN)|RAPT Therapeutics, Inc. - Share Price|Stock Price JBIO (Aerovate Therapeutics)|Aclaris (ACRS) - Market Price|KYTX - Price Chart|Tiziana Life Sciences - Price|CABA: Stock Price|Market Price Ventyx Biosciences Inc. (VTYX)|THTX (theratech.com) - Stock Price|Stock Price Avalo Therapeutics Inc|Stock Price ELDN|Agenus Inc. - Share Price|Stock Price CLYM (Climb Bio)|Price Performance Chart ZURA|ATYR - Price Chart|ADAG (adagene.com) - Share Price|IMA: Stock Price|Stock Quotes Shattuck Therapeutics|Stock Quotes EQ|CNTB: Price Performance Chart|Stock Price IMUX|ATRA - Market Price|inflarx.de - Stock Quotes|Stock Price X4 Pharma XFOR|Adicet Bio - Stock Price|Price Performance Chart CELU (celularity.com)|INMB: Stock Price|BRNS - Market Chart|KZR (kezarlifesciences.com) - Stock Price|SAB Biotherapeutics - Quote Chart|Stock Quotes AKTX (akaritx.com)|ENLV: Quote Chart|Stock Price QTTB (Q32 Bio Corp)|GOVX - Stock Quotes|EDSA - Price Chart|IBIO - Stock Price|CARM (carismatx.com) - Stock Quotes|XTLB: Price|BOLT (Bolt Biotherapeutics, Inc.) - Stock Price|HCW Biologics Inc. (HCWB) - Market Chart|Price Chart Aptevo (APVO)|Stock Price aimimmuno.com (AIM)|Price Chart Aditxt ADTX|Stock Price GRI Bio Corp GRI|XRTX - Price Chart|HIND (ReShape Lifesciences) - Share Price|revbiosciences.com (REVB) - Price Chart|INDP - Market Chart|SCNI (Scinai Immunotherapeutics Ltd) - Stock Price|Stock Price calcimedica.com|Stock Price AFMD|Market Chart Allakos Inc|Stock Price HOOK (HOOKIPA Pharma Inc.)|IGMS (IGM Bio) - Quote Chart|ITOS - Price Chart|Quote Chart OCEA|TC Biopharm (TCBP) - Price Chart|Stock Quotes Third Harmonic Bio, Inc